Anavex Life Sciences (AVXL)
Develops oral investigational therapies for neurodegenerative and neurodevelopmental diseases.
$2.34
vs last close−0.14 (−5.47%)
Something off on this page? Send us feedback.
Next report
Nov 24, 26
in 62 days
EPS estimate
−$0.11
Revenue estimate
—
Fiscal quarter
Q4 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26Aug '26Aug '26Nov '26
Reported−$0.14−$0.13−$0.16−$0.11−$0.06$0.08−$0.03Pending
Estimate−$0.17−$0.16−$0.13−$0.13−$0.10−$0.08−$0.08−$0.11
Surprise+17.6%+18.8%−23.1%+15.4%+40.0%+200.0%+62.5%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26Aug '26Aug '26Nov '26
Reported———————Pending
Estimate—$45.5M$71.7M$111.6M————
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Sep 2028 | $0.59 | — | — |
| Jun 2028 | $0.56 | — | — |
| Mar 2028 | $0.56 | — | — |
| Dec 2027 | $0.55 | — | — |
| Sep 2027 | −$0.15 | — | — |
| Jun 2027 | −$0.14 | — | — |
| Mar 2027 | −$0.13 | — | — |
| Dec 2026 | −$0.12 | — | — |
| Nov 2026 | −$0.11 | — | — |
| Aug 2026 | −$0.08 | −$0.03 | +62.5% |
| Aug 2026 | −$0.08 | $0.08 | +200.0% |
| Feb 2026 | −$0.10 | −$0.06 | +40.0% |
| Nov 2025 | −$0.13 | −$0.11 | +15.4% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Dec 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Dec 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Dec 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Dec 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Dec 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Dec 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Dec 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Sep 2028 | $0.59 | — | — | $0 | — | — | — |
| Jun 2028 | $0.56 | — | — | $0 | — | — | — |
| Mar 2028 | $0.56 | — | — | $0 | — | — | — |
| Dec 2027 | $0.55 | — | — | $0 | — | — | — |
| Sep 2027 | −$0.15 | — | — | $0 | — | — | — |
| Jun 2027 | −$0.14 | — | — | $0 | — | — | — |
| Mar 2027 | −$0.13 | — | — | $0 | — | — | — |
| Dec 2026 | −$0.12 | — | — | $0 | — | — | — |
| Nov 24, 2026 | −$0.11 | — | — | $0 | — | — | — |
| Aug 28, 2026 | −$0.08 | −$0.03 | +62.5% | — | — | — | −6.4% |
| Aug 25, 2026 | −$0.08 | $0.08 | +200.0% | — | — | — | +14.5% |
| Feb 9, 2026 | −$0.10 | −$0.06 | +40.0% | — | — | — | +6.1% |
| Nov 25, 2025 | −$0.13 | −$0.11 | +15.4% | $111.6M | — | — | +12.3% |
| Aug 12, 2025 | |||||||
| May 13, 2025 | |||||||
| Feb 12, 2025 | |||||||
| Dec 23, 2024 | |||||||
| Aug 6, 2024 | |||||||
| May 9, 2024 | |||||||
| Feb 7, 2024 | |||||||
| Nov 27, 2023 | |||||||
| Aug 8, 2023 | |||||||
| May 9, 2023 | |||||||
| Feb 7, 2023 | |||||||
| Nov 28, 2022 | |||||||
| Aug 9, 2022 | |||||||
| May 10, 2022 | |||||||
| Feb 9, 2022 | |||||||
| Nov 24, 2021 | |||||||
| Aug 12, 2021 | |||||||
| May 13, 2021 | |||||||
| Feb 11, 2021 | |||||||
| Dec 28, 2020 | |||||||
| Aug 6, 2020 | |||||||
| May 7, 2020 | |||||||
| Feb 6, 2020 | |||||||
| Dec 16, 2019 | |||||||
| Aug 7, 2019 | |||||||
| May 8, 2019 | |||||||
| Feb 7, 2019 | |||||||
| Dec 12, 2018 | |||||||
| Aug 9, 2018 | |||||||
| May 10, 2018 | |||||||
| Feb 7, 2018 | |||||||
| Dec 11, 2017 | |||||||
| Aug 7, 2017 | |||||||
| May 10, 2017 | |||||||
| Feb 7, 2017 | |||||||
| Dec 12, 2016 | |||||||
| Aug 11, 2016 | |||||||
| May 11, 2016 | |||||||
| Feb 8, 2016 | |||||||
| Dec 29, 2015 | |||||||
| Aug 17, 2015 |